文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > 2014 TO P Modulation of gamma globin genes expression by histone deacetylase Inhibitors
侵权投诉

2014 TO P Modulation of gamma globin genes expression by histone deacetylase Inhibitors

L.Ronzonietal

Bauer,D.E.&Orkin,S.H.(2011)Updateonfetalhemoglobingeneregulationinhemoglo-binopathies.CurrentOpinioninPediatrics,23,1–8.

Bradner,J.E.,Mak,R.,Tanguturi,S.K.,Mazit-schek,R.,Haggarty,S.J.,Ross,K.,Chang,C.Y.,Bosco,J.,West,N.,Morse,E.,Lin,K.,Shen,J.P.,Kwiatkowski,N.P.,Gheldof,N.,Dekker,J.,DeAngelo,D.J.,Carr,S.A.,Schreiber,S.L.,Golub,T.R.&Ebert,B.L.(2010)Chemicalgeneticstrategyidenti eshistonedeacetylase1(HDAC1)andHDAC2astherapeuticstargetsinsicklecelldisease.ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesofAmer-ica,107,12617–12622.

Calzada,A.A.,Todoerti,K.,Donadoni,L.,Pellicci-oli,A.,Tuana,G.,Gatta,R.,Neri,A.,Finazzi,G.,Mantovani,R.,Rambaldi,A.,Introna,M.,Lombardi,L.&Golay,J.(2012)TheHDACinhibitorGivinostatmodulatesthehematopoi-etictranscriptionfactorsNFE2andC-MYBinJAKV617Fmyeloproliferativeneoplasmcells.ExperimentalHematology,40,634–645.

Cao,H.,Stamatoyannopulos,G.&Jung,M.(2004)Inductionofhumancglobingeneexpressionbyhistonedeacetilasehinibitors.Blood,103,2.

Cappellini,M.D.,Graziadei,G.,Ciceri,L.,Comi-no,A.,Bianchi,P.,Porcella,A.&Fiorelli,G.(2000)Oralisobutyramidetherapyinpatientswithtalassemiaintermedia:resultsofaphaseIIopenstudy.BloodCellsMoleculesandDiseases,26,105–111.

Chomczynski,P.&Sacchi,N.(2006)Thesingle-stepmethodofRNAisolationbyacidguanidiniumthiocyanate-phenol-chloroformextraction:twenty-somethingyearson.NatureProtocols,1,581–585.Collins,A.F.,Pearson,H.A.,Giardina,P.,McDo-angh,K.T.,Brusilow,S.W.&Dover,G.J.(1995)Oralsodiumphenyilbutyratetherapyinhomo-zygousbetathalassemia:aclinicaltrial.Blood,85,43–49.

DeFranceschi,L.&Corrocher,R.(2004)Estab-lishedandexperimentaltreatmentsforsicklecelldisease.Haematologica,89,348–356.

Furlan,A.,Monzani,V.,Reznikov,L.L.,Leoni,F.,Fossati,G.,Modena,D.,Mascagni,P.&Dina-rello,C.A.(2011)Pharmacokinetics,safetyandinduciblecytokineresponsesduringaphase1trialoftheoralhistonedeacetylaseinhibitor

8ITF2357(givinostat).MolecularMedicine,17,Ronzoni,L.,Bonara,P.,Rusconi,D.,Frugoni,C.,353–362.

Libani,I.&Cappellini,M.D.(2008)ErythroidGolay,J.,Cuppini,L.,Leoni,F.,Mic o

,C.,Barbui,differentiationandmaturationfromperipheralV.,Domenghini,M.,Lombardi,L.,Neri,A.,CD34+cellsinliquidculture:cellularandBarbui,A.M.,Salvi,A.,Pozzi,P.,Porro,G.,molecularcharacterization.BloodCells,Mole-Pagani,P.,Fossati,G.,Mascagni,P.,Introna,M.culesandDiseases,40,148–155.

&Rambaldi,A.(2007)ThehistonedeacetylaseSankaran,V.G.(2011)Targetedtherapeuticstrate-inhibitorITF2357hasanti–leukemicactivityingiesforfetalhemoglobininduction.HematologyvitroandinvivoandinhibitsIL–6andVEGFAmericanSocietyofHematologyEducationproductionbystromalcells.Leukemia,21,Program,2011,459–465.

1892–1900.

Steinberg,M.H.&Sebastiani,P.(2012)GeneticHiggs,D.R.,Engel,J.D.&Stamatoyannopulos,G.modi ersofsicklecelldisease.AmericanJournal(2012)Thalassemia.Lancet,379,373–383.

ofHematology,87,795–803.

Johnson,J.,Hunter,R.,McElveen,R.,Qian,X.H.,Balig-Steinberg,M.H.,Barton,F.,Castro,O.,Pegelow,a,B.S.&Pace,B.S.(2005)Fetalhemoglobininduc-C.H.,Ballas,S.K.,Kutlar,A.,Orringer,E.,Belle-tionbythehistonedeacetylaseinhibitor,scriptaid.vue,R.,Olivieri,N.,Eckman,J.,Varma,M.,Ra-CellularandMolecularBiology,51,229–238.

mirez,G.,Adler,B.,Smith,W.,Carlos,T.,Leoni,F.,Fossati,G.,Lewis,E.C.,Lee,J.K.,Porro,Ataga,K.,DeCastro,L.,Bigelow,C.,Saunthar-G.,Pagani,P.,Modena,D.,Moras,M.L.,Pozzi,arajah,Y.,Telfer,M.,Vichinsky,E.,Claster,S.,P.,Reznikov,L.L.,Siegmund,B.,Fantuzzi,G.,Shurin,S.,Bridges,K.,Waclawiw,M.,Bonds,D.Dinarello,C.A.&Mascagni,P.(2005)The&Terrin,M.(2003)EffectofhydroxyureaonhystonedeacetylasehinibitorITF2357reducesmortalityandmorbidityinadultsicklecellane-productionofpro–in ammatorycytokinesinmia:risksandbene tsupto9yearsoftreat-vitroandsystemicin ammationinvivo.Molec-ment.TheJournalofAmericanMedicalularMedicine,11,1–15.

Association,289,1645–1651.

Moutouh-deParseval,L.,Verhelle,D.&Chan,K.Testa,U.(2009)Fetalhemoglobinchemicalinduc-(2008)Pomalidomideandlenalidomideregulateersfortreatmentofhemoglobinopathies.AnnalserythropoiesisandfetalhemoglobinproductionofHematology,88,505–528.

inhumanCD34+cells.TheJournalofClinicalThein,S.L.(2005)Pathophysiologyofbetathalas-Investigation,118,248–258.

semia–aguidetomoleculartherapies.Hema-Musallam,K.M.,Sankaran,V.G.,Cappellini,M.D.,tologyAmericanSocietyofHematolologyDuca,L.,Nathan,D.G.&Taher,A.T.(2012)EducationProgram,31–37.

Fetalhemoglobinlevelsanmorbidityinun-Thein,S.L.(2008)Geneticmodi ersofthebeta-transfusedpatientswithbeta–thalassemiahaemoglobinopathies.BritishJournalofHaema-intermedia.Blood,119,364–367.

tology,141,357–366.

Musallam,K.M.,Taher,A.T.,Cappellini,M.D.&Thein,S.L.(2012)TheemergingroleoffetalSankaran,V.G.(2013)Clinicalexperiencewithhemoglobininductioninnon-transfusion-fetalhemoglobininductiontherapyinpatientsdependent-thalassemia.BloodReviews,26,S35–withb-thalassemia.Blood,121,2199–2212.

S39.

Perrine,S.P.(2005)Fetalglobininduction–canitVojinovic,J.&Damjanov,N.(2011)HDACinhi-curebetathalassemia?AmericanSocietyofbitioninrheumatoidarthritisandjuvenileidio-HematologyEducationProgram,38–44.

pathicarthritis.MolecularMedicine,17,397–Perrine,S.P.,Castaneda,S.A.,Chui,D.H.K.,Faller,403.

D.V.,Berenson,R.J.,Siritanaratku,N.&Fucha-Weatherall,D.J.(1997)Thethalassemias.Britishroen,S.(2010)Fetalglobingeneinducers:novelMedicalJournal,314,1675–1678.

agentsandnewpotential.AnnalsoftheNewWitt,O.,Monkemeyer,S.,R€o

nndahl,G.,Erdlenb-YorkAcademyofSciences,1202,158–164.

ruch,B.,Reinhardt,D.,Kanbach,K.&Pekrun,Platt,O.S.(2008)HydroxyureaforthetreatmentA.(2003)Inductionoffetalhemoglobinexpres-ofsicklecellanemia.TheNewEnglandJournalsionbythehistonedeacetylaseinhibitorapici-ofMedicine,358,1362–1369.

din.Blood,101,2001–2007.

ª2014JohnWiley&SonsLtd,BritishJournalofHaematology

上一页第8页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email